Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

NVAX – Novavax, Inc.

Novavax, Inc.
NVAX
$8.67
Name : Novavax, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,425,678,464.00
EPSttm : -0.56
finviz dynamic chart for NVAX
Novavax, Inc.
$8.67
0.58%
$0.05
NVAX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

29

Margin Of Safety %

Put/Call OI Ratio

0.45

EPS Next Q Diff

-0.09

EPS Last/This Y

-3.19

EPS This/Next Y

0.22

Price

8.68

Target Price

14.11

Analyst Recom

2.44

Performance Q

-18.9

Upside

-342.2%

Beta

2.45

Ticker: NVAX




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11NVAX9.50.450.14254994
2026-05-12NVAX9.630.440.08262836
2026-05-13NVAX9.240.430.07270198
2026-05-14NVAX9.360.430.23271315
2026-05-15NVAX9.070.440.10274468
2026-05-18NVAX8.930.450.32229666
2026-05-19NVAX8.910.450.84236019
2026-05-20NVAX9.260.460.22238150
2026-05-21NVAX8.980.450.12241206
2026-05-22NVAX9.220.460.13240919
2026-05-26NVAX10.470.460.21230426
2026-05-27NVAX11.10.450.19241375
2026-05-28NVAX10.320.440.17248498
2026-05-29NVAX10.960.430.31252240
2026-06-02NVAX10.220.440.26238934
2026-06-03NVAX10.210.430.10241720
2026-06-04NVAX10.180.430.07242527
2026-06-05NVAX9.470.430.31245463
2026-06-08NVAX8.60.450.49234364
2026-06-09NVAX8.680.450.16237608
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11NVAX9.51-110.9- -0.36
2026-05-12NVAX9.63-48.4- -0.36
2026-05-13NVAX9.23-48.4- -0.36
2026-05-14NVAX9.36-167.7- -0.36
2026-05-15NVAX9.07-167.7- -0.53
2026-05-18NVAX8.92-167.7- -0.53
2026-05-19NVAX8.91-167.7- -0.53
2026-05-20NVAX9.26-167.7- -0.53
2026-05-21NVAX8.99-167.7- -0.53
2026-05-22NVAX9.21-167.7- -0.47
2026-05-26NVAX10.47-167.7- -0.47
2026-05-27NVAX11.10-167.7- -0.47
2026-05-28NVAX10.31-167.7- -0.47
2026-05-29NVAX10.96-167.7- -0.47
2026-06-01NVAX10.52-100.0- -0.47
2026-06-02NVAX10.24-100.0- -0.47
2026-06-03NVAX10.20-100.0- -0.47
2026-06-04NVAX10.17-100.0- -0.47
2026-06-05NVAX9.48-100.0- -0.47
2026-06-08NVAX8.60-100.0- -0.47
2026-06-09NVAX8.68-100.0- -0.47
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11NVAX0.002.5829.64
2026-05-12NVAX0.002.5831.65
2026-05-13NVAX0.002.5831.65
2026-05-14NVAX0.002.5831.65
2026-05-15NVAX0.002.5831.65
2026-05-18NVAX0.000.9531.65
2026-05-19NVAX0.000.9531.65
2026-05-20NVAX0.000.9531.65
2026-05-21NVAX0.000.9531.65
2026-05-22NVAX0.000.9531.65
2026-05-26NVAX0.00-0.0631.65
2026-05-27NVAX0.00-0.0631.65
2026-05-28NVAX0.00-0.0629.00
2026-05-29NVAX0.00-0.0629.00
2026-06-02NVAX0.00-0.8229.00
2026-06-03NVAX0.00-0.8229.00
2026-06-04NVAX0.00-0.8229.00
2026-06-05NVAX0.00-0.8229.00
2026-06-08NVAX0.00-0.8229.00
2026-06-09NVAX0.00-0.8229.00
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.15

Insider Transactions

Institutional Transactions

-0.82

Beta

2.45

Average Sales Estimate Current Quarter

58

Average Sales Estimate Next Quarter

108

Fair Value

Quality Score

33

Growth Score

23

Sentiment Score

7

Actual DrawDown %

96.9

Max Drawdown 5-Year %

-98.6

Target Price

14.11

P/E

Forward P/E

PEG

P/S

2.39

P/B

P/Free Cash Flow

EPS

-0.6

Average EPS Est. Cur. Y​

-0.47

EPS Next Y. (Est.)

-0.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.73

Relative Volume

0.97

Return on Equity vs Sector %

33.2

Return on Equity vs Industry %

49.4

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.1

EBIT Estimation

NVAX Healthcare
$8.67
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
18/25
Volume
7/15
Valuation
12/20
TP/AR
3/10
Options
8/10
RSI
42
Range 1M
12.1%
Sup Dist
4.8%
🚀
Momentum Growth
Ride accelerating trends
N/A
25 /100
WEAK
Momentum
3/25
Growth
11/30
Estimates
2/20
Inst/Vol
2/15
Options
7/10
EPS Yr
-118.3%
EPS NY
42.8%
52W%
44.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +62.7% upside
Quality
7/30
Valuation
14/30
Growth
10/25
Stability
7/10
LT Trend
1/5
Upside
+62.7%
Quality
33
Novavax, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 749
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
NVAX

Latest News

Caricamento notizie per NVAX
stock quote shares NVAX – Novavax, Inc. Stock Price stock today
news today NVAX – Novavax, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NVAX – Novavax, Inc. yahoo finance google finance
stock history NVAX – Novavax, Inc. invest stock market
stock prices NVAX premarket after hours
ticker NVAX fair value insiders trading